DEKA
340 Commercial Street
Manchester
New Hampshire
03101
United States
Tel: 603-669-5139
Website: http://www.dekaresearch.com/
About DEKA
DEKA Research & Development Corp. is a New Hampshire based company that brings expertise to the world of complex problem solving and improving lives.YEAR FOUNDED:
1982
LEADERSHIP:
Founder: Dean Kamen
CEO: Nadav Shraibom
JOBS:
Please click here for DEKA job opportunities.
8 articles about DEKA
-
After the Great Success Achieved in the United States and Canada, DEKA Launches Three Extraordinary Laser and Microwave Platforms at the World Congress of Dermatology in Singapore
7/3/2023
DEKA, a subsidiary of the El.En. Group, a company listed on the Eurostar Next of the Italian Stock Exchange, specialized in the development and manufacturing of cutting-edge Energy Based Devices for Aesthetics and Surgery, has announced the launch of its new “PRO” line, based on laser and microwave devices, at the 25th WCD Congress, which will be held in Singapore from July 3 until July 8.
-
Zealand Pharma shared positive top-line results for its second Phase III clinical trial of its congenital hyperinsulinism (CHI) drug, dasiglucagon, in pediatric patients.
-
Deka Biosciences Raises USD 20 Million in Series A Financing
11/16/2021
Deka Biosciences today announced that it has successfully closed a USD 20 Million Series A financing with a syndicate of life science investors led by Leaps by Bayer
-
Zealand Pharma and DEKA Research & Development Corp. Announce Collaboration Agreement to Advance Development of Infusion Pump to Be Used with Dasiglucagon for Treatment of Congenital Hyperinsulinism (CHI)
11/5/2021
Zealand Pharma today announced that it has entered into definitive collaboration agreements with DEKA Research & Development Corp., to develop a continuous infusion pump to be used in combination with dasiglucagon, an investigational agent currently in phase 3 trials in patients with congenital hyperinsulinism.
-
Satellite Healthcare Participates in Clinical Trial With Home Hemodialysis Machine
6/14/2021
Satellite Healthcare announced it will participate in an ongoing clinical trial sponsored by DEKA Research & Development Corp.
-
DEKA (El.En. Group) Establishes a Medical Advisory Board for Female Intimate Health
11/24/2020
DEKA M.E.L.A. Srl, a laser and opto-electronics company engaged in the development of gynecological energy based devices and therapies for the treatment of women health diseases, announced the establishment of its Medical Advisory Board for Female Intimate Health.
-
United Therapeutics And DEKA Announce FDA Clearance Of The Unity Subcutaneous Delivery System For Remodulin®
5/7/2019
United Therapeutics Corporation and DEKA Research & Development Corp.
-
With $294 Million, DEKA's Founder Hopes to Bring Regenerative Medicine "Up to Scale"
2/7/2017